A retrospective, observational study sponsored by G1 Therapeutics described the burden of myelosuppression and its impact on healthcare resource utilization in 3,277 patients being treated with chemotherapy for extensive-stage small-cell lung cancer. The study also described patient outcomes from 21 patients receiving Cosela (trilaciclib) prior to chemotherapy.
The Lung Cancer Research Foundation announced funding opportunities to advance lung cancer research, including two new Team Science awards and an Early Career Investigator award.
